Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YHP1701 in Patients With Dyslipidemia and Hypertension
NCT03103256Phase 3Completed
- Sponsor
- Yuhan
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, rosuvastatin in hypertension (HTN), dyslipidemia, sponsored by Yuhan. Started May 2017; status: completed.
02
Drugs
telmisartanrosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT03103256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103256.